Phage-display peptide libraries have been widely used to identify specific peptides targeting in vivo tumor cells and the tumor vasculature and playing an important role in the discovery of antitumor bioactive peptides. in the present work, we identified a new melanoma-homing peptide, (-CVNHPAFAC-), using a C7C phage-display library directed to the developing tumor in syngeneic mice. Phage were able to preferentially target melanoma in vivo, with an affinity about 50-fold greater than that with normal tissue, and the respective synthesized peptide displaced the corresponding phage from the tumor. A preferential binding to endothelial cells rather than to melanoma cells was seen in cell ELISA, suggesting that the peptide is directed to the m...
Cancer is a disease advanced via surplus angiogenesis. The development of new anti-angiogenic therap...
Accounting for 16 million new cases and 9 million deaths annually, cancer leaves a great number of p...
Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel treatment stra...
Phage-display peptide libraries have been widely used to identify specific peptides targeting in viv...
Phage-display peptide libraries have been widely used to identify specific peptides targeting in viv...
Antiangiogenesis therapies for the treatment of cancers hold the promise of high efficacy and low to...
Although the VEGF-Flk-1-pathway has been known as the major driving force of angiogenesis, new evide...
Lung cancer is the leading cause of cancer-related mortality worldwide. The lack of tumor specificit...
Lung cancer is the leading cause of cancer-related mortality worldwide. The lack of tumor specificit...
Background Tumor growth depends on pro-angiogenic vascular endothelial growth factors (VEGF-A/-B) vi...
Monoclonal antibodies have been successfully utilized as cancer-targeting therapeutics and diagnosti...
Selective targeting of drugs to tumor cells is a key goal in oncology. Here, we performed an in vivo...
We developed a screening procedure to identify ligands from a phage display random peptide library t...
The vasculature of each organ expresses distinct molecular signatures critically influenced by the p...
Abstract We report here the selection and characterization of a novel peptide ligand using phage dis...
Cancer is a disease advanced via surplus angiogenesis. The development of new anti-angiogenic therap...
Accounting for 16 million new cases and 9 million deaths annually, cancer leaves a great number of p...
Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel treatment stra...
Phage-display peptide libraries have been widely used to identify specific peptides targeting in viv...
Phage-display peptide libraries have been widely used to identify specific peptides targeting in viv...
Antiangiogenesis therapies for the treatment of cancers hold the promise of high efficacy and low to...
Although the VEGF-Flk-1-pathway has been known as the major driving force of angiogenesis, new evide...
Lung cancer is the leading cause of cancer-related mortality worldwide. The lack of tumor specificit...
Lung cancer is the leading cause of cancer-related mortality worldwide. The lack of tumor specificit...
Background Tumor growth depends on pro-angiogenic vascular endothelial growth factors (VEGF-A/-B) vi...
Monoclonal antibodies have been successfully utilized as cancer-targeting therapeutics and diagnosti...
Selective targeting of drugs to tumor cells is a key goal in oncology. Here, we performed an in vivo...
We developed a screening procedure to identify ligands from a phage display random peptide library t...
The vasculature of each organ expresses distinct molecular signatures critically influenced by the p...
Abstract We report here the selection and characterization of a novel peptide ligand using phage dis...
Cancer is a disease advanced via surplus angiogenesis. The development of new anti-angiogenic therap...
Accounting for 16 million new cases and 9 million deaths annually, cancer leaves a great number of p...
Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel treatment stra...